Author

E. Synolaki

Observed name: E Synolaki

Institution: Velocity Clinical Research (United States)

Observed institutions: University of Copenhagen, Duke University, National and Kapodistrian University of Athens, Rigshospitalet, Velocity Clinical Research (United States), Duke University Health System, Centre of Excellence for Health, Immunity and Infections, Evangelismos Hospital

OpenAlex ID: A5068797994

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

Works count: 4

Citation count: 110

H-index: 4

I10-index: 3